Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · IEX Real-Time Price · USD
15.28
-0.13 (-0.84%)
Apr 19, 2024, 2:10 PM EDT - Market open

Gyre Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2003
Net Income
-92.932.3-87.93-56.24-55.18-30.06-25.51-16.95-14.76-6.61
Upgrade
Depreciation & Amortization
1.431.490.290.140.150.150.170.390.470.68
Upgrade
Share-Based Compensation
7.2813.373.413.633.22.610.860.640.330.24
Upgrade
Other Operating Activities
110.12-6.480.48-2.578.22-1.250.59-2.55-5.15-0.7
Upgrade
Operating Cash Flow
25.8910.68-83.76-55.05-43.61-28.55-19.94-18.47-19.12-6.39
Upgrade
Operating Cash Flow Growth
142.50%---------
Upgrade
Capital Expenditures
-7.85-4.99-0.84-0.27-0.06-0.38-0.020.42-0.270.1
Upgrade
Acquisitions
4.9000000023.930
Upgrade
Change in Investments
-16.74-8.8249.039.9327.46-70.95-11.17-3.413.820
Upgrade
Other Investing Activities
-0.07-0.01-----1.67-0.13-
Upgrade
Investing Cash Flow
-19.76-13.8148.199.6627.39-71.32-11.2-1.3137.360.1
Upgrade
Share Issuance / Repurchase
0049.5560.380.33116.4135.40.96-0.070.03
Upgrade
Debt Issued / Paid
00000-5.08-14.32-14.34-1.130
Upgrade
Other Financing Activities
2.5------14.3310.514.98
Upgrade
Financing Cash Flow
2.5049.5560.380.33111.3321.080.959.315.01
Upgrade
Exchange Rate Effect
-0.3-1.8900000000
Upgrade
Net Cash Flow
8.33-5.0313.9914.99-15.8911.46-10.05-18.8327.55-1.28
Upgrade
Free Cash Flow
18.045.69-84.59-55.32-43.68-28.93-19.96-18.05-19.39-6.29
Upgrade
Free Cash Flow Growth
216.92%---------
Upgrade
Free Cash Flow Margin
15.90%5.56%-1152.82%-264.06%---1961.00%-4523.81%-1108.00%-346.99%
Upgrade
Free Cash Flow Per Share
0.270.09-41.41-43.26-54.58-38.70-87.46-347.49-985.02-3850.73
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).